Global Neuromodulation Devices Market OverviewThe global neuromodulation devices market is poised to witness substantial ...

The rising incidences of chronic pain, neurological disorders and mental health conditions continue to drive the demand for ...

Medtronic beat second-quarter estimates and raised annual sales growth forecast on Tuesday, driven by strong demand for heart ...

Medtronic has promoted the head of its Cardiac Implantables Technology Development Center to be its new chief technology ...

Medtronic pulsed-field ablation offerings enabled the company to more than double its U.S. cardiac ablation sales during a ...

Medtronic reported second-quarter profit and revenue above Wall Street estimates on Tuesday, driven by strong demand for its ...

Medtronic has reported 6.6% revenue growth to $9B in Q2 2026, led by its cardiovascular portfolio's 10.8% increase and 71% ...

"In sum, although the court previously rejected (and thus did not consider) the application of a but-for causation standard, ...

Medtronic raised its fiscal year 2026 organic revenue growth guidance to 5.5% from 5%. The medical devices giant raised ...

The internal neuromodulation devices market is surging, powered by personalized AI and smaller hardware. As these smart, ...

Deep brain stimulation – implants in the brain that act as a kind of 'pacemaker' – has led to clinical improvements in half of the participants with treatment-resistant severe depression in an 'open ...